Combination of Nilotinib and Pegylated Interferon Alfa-2b Results in High Molecular Response Rates in Chronic Phase CML: Interim Results of the ALLG CML 11 Pinnacle Study

David T Yeung, Andrew P Grigg, Naranie Shanmuganathan, Ilona Cunningham, Jake Shortt, Philip Rowling, John Reynolds, Rachel Cushion, Rosemary Anne Harrup, David M Ross, David Kipp, Anthony K Mills, Christopher K Arthur, Anthony P Schwarer, Kathryn Jackson, Nicholas Viiala, Robert Weinkove, Agnes SM Yong, Deborah L White, Susan Branford Show all